One‐Step RAA and CRISPR ‐Cas13a Method for Detecting Influenza B Virus

Apr 15, 2025Microbial biotechnology

Rapid One-Step Test Using CRISPR to Detect Influenza B Virus

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

The CRISPR-based Rapid and Efficient Test (CRISPRET) demonstrates a detection limit of 500 copies·μL for Influenza B virus nucleic acid.

CRISPRET achieves high sensitivity of 100% and specificity of 97.69% when tested against clinical samples.
Positive predictive value (PPV) and negative predictive value (NPV) are both 97.69% and 100%, respectively.
The method shows a concordance rate of 98.83% compared to quantitative PCR (qPCR).
Detection of IBV nucleic acid can occur within approximately the first 5 minutes of the reaction.
CRISPRET is designed for early diagnosis and may shorten the transmission chain of Influenza B.

AI simplified

We developed a sensitive and specific method based on recombinase-aided amplification (RAA) and clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 13a (Cas13a). This method, named CRISPR-based Rapid and Efficient Test (CRISPRET), is designed for the early diagnosis of Influenza B (FluB) with the aim of shortening its transmission chain. We identified conserved regions in the Influenza B Virus (IBV) NS gene and designed forward and reverse primers along with crRNAs. We then established and optimised the reaction system, and Nucleic Acid Positive Reference Materials of IBV were used to evaluate the detection limit (DL) of CRISPRET. Additionally, we collected 257 clinical samples, comprising 127 samples from patients with IBV infection and 130 samples from healthy individuals, and subjected them to dual detection using CRISPRET and qPCR to evaluate the positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity of CRISPRET. We designed one forward primer, two reverse primers, and two crRNAs to establish and optimise the CRISPR ET. The method demonstrated the DL of 500 copies·μLwhen assisted by appropriate equipment. Despite requiring auxiliary equipment and a 30-min reaction, the CRISPR ET method enables the detection of IBV nucleic acid within approximately the first 5 min, achieving high sensitivity (100%), specificity (97.69%), PPV (97.69%) and NPV (100%), with a concordance rate of 98.83% to qPCR. CRISPRET offers a simple, field-applicable, one-step method for the rapid detection of IBV. It has strong potential for field-testing applications and intelligent integration into existing diagnostic systems. -1

Key numbers

100%

Sensitivity

True positive rate for IBV detection using CRISPRET.

97.69%

Specificity

True negative rate for IBV detection using CRISPRET.

98.83%

Concordance Rate

Rate of agreement in detection results between CRISPRET and qPCR.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text ↗

One‐Step RAA and CRISPR ‐Cas13a Method for Detecting Influenza B Virus

Abstract

Key numbers

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Key numbers

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief